Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001628280-16-021725)

Filing Details

Accession Number:: 0001628280-16-021725
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-11-30 15:31:48
Reporting Period:: 2016-11-29

Filing Date:: 2016-11-30
Accepted Time:: 2016-11-30 15:31:48
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1600132	Bellerophon Therapeutics Inc.	BLPH	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1500241	M Jonathan Peacock	C/O Bellerophon Therapeutics, Inc. 184 Liberty Corner Road, Suite 302 Warren NJ 07059		Yes	No	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2016-11-29	285,715	$0.00	508,417	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Common Stock Warrants (right to buy)	Acquisiton	2016-11-29	285,715	$0.00	285,715	$0.80

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
285,715	2016-11-29	2021-11-29	No	4	P	Direct

Footnotes

The reported securities are included within 285,715 Class A Units purchased by the reporting person for $0.70 per Class A Unit. Each Class A Unit consists of one share of common stock and one warrant to purchase one share of common stock.